Insight

Talal El Zarif: Non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling

Photo of Talal El Zarif from medicine.yale.edu

Jun 28, 2024, 12:15

Talal El Zarif: Non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling

Talal El Zarif, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: .

“Out now in Clinical Cancer Research! We demonstrate accurate non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling! Led by Catherine Meador, Xintao Qiu and guided by Jacob Berchuck and Matthew Freedman.”

Visit the article website.
Source: Talal El Zarif/X

cancer Catherine Meador Clinical Cancer Research Dana-Farber Cancer Institute EGFRm lung adenocarcinoma epigenomic cfDNA profiling Jacob Berchuck Matthew Freedman OncoDaily Oncology small cell transformation Talal El Zarif Xintao Qiu

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage